{"id":"nimodipine-group","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Gastrointestinal disturbances"}]},"_chembl":{"chemblId":"CHEMBL1428","moleculeType":"Small molecule","molecularWeight":"418.45"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nimodipine preferentially acts on cerebral blood vessels compared to peripheral vessels, reducing vasospasm and improving microcirculation in the brain. By blocking calcium influx into vascular smooth muscle cells, it prevents vasoconstriction and enhances oxygen delivery to ischemic brain tissue. This mechanism is particularly beneficial in conditions involving cerebral vasospasm and reduced cerebral perfusion.","oneSentence":"Nimodipine is a dihydropyridine calcium channel blocker that selectively inhibits L-type calcium channels in vascular smooth muscle, causing vasodilation and improved cerebral blood flow.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:23:03.458Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Subarachnoid hemorrhage with cerebral vasospasm"},{"name":"Ischemic stroke prevention and treatment"}]},"trialDetails":[{"nctId":"NCT06603181","phase":"NA","title":"Effect of Extracorporeal Shock Wave Therapy (ESWT) and Phonophoresis Treatment in Patients With Lateral Epicondylitis","status":"COMPLETED","sponsor":"Kirsehir Ahi Evran Universitesi","startDate":"2024-09-25","conditions":"Lateral Epicondylitis, Extracorporeal Shock Wave Therapy, Phonophoresis","enrollment":60},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT07144956","phase":"PHASE3","title":"Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier St Anne","startDate":"2025-12-15","conditions":"Aneurysmal Subarachnoid Hemorrhage","enrollment":630},{"nctId":"NCT06898125","phase":"NA","title":"Evaluation of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy Results in Patients With Lipedema","status":"COMPLETED","sponsor":"Giresun University","startDate":"2023-09-01","conditions":"Lipedema, Pain","enrollment":33},{"nctId":"NCT06987721","phase":"","title":"Extracorporeal Shock-wave Therapy in Myofascial Pain Syndrome","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2022-01-18","conditions":"Myofacial Pain Syndrome","enrollment":57},{"nctId":"NCT06321276","phase":"NA","title":"Investigation of the Efficiency of Radial Extracorporeal Shock Wave Therapy at Different Pulses in Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"Ahi Evran University Education and Research Hospital","startDate":"2023-11-01","conditions":"Carpal Tunnel Syndrome","enrollment":98},{"nctId":"NCT06712329","phase":"NA","title":"Chronic Plantar Fasciitis: Which is More Effective? Prolotherapy/Extracorporeal Shock Wave Therapy?","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2023-10-01","conditions":"Chronic Plantar Fasciitis","enrollment":70},{"nctId":"NCT06717633","phase":"PHASE3","title":"Comparison of Short-term Effects of Extracorporeal Shock Wave Therapy, Low-level Laser Therapy and Pulsed Electromagnetic Field Therapy in Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Istanbul Medeniyet University","startDate":"2024-01-01","conditions":"Knee Osteoarthritis","enrollment":120},{"nctId":"NCT05118945","phase":"","title":"Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update","status":"COMPLETED","sponsor":"Kinderkrankenhaus auf der Bult","startDate":"2021-03-03","conditions":"Type 1 Diabetes, Insulin Therapy","enrollment":50},{"nctId":"NCT06007573","phase":"NA","title":"Acupuncture Combined With Nimodipine for Prevention of Post-stroke Dementia","status":"COMPLETED","sponsor":"Yuzhen Pan","startDate":"2021-02-01","conditions":"Post-stroke Dementia","enrollment":40},{"nctId":"NCT05689593","phase":"NA","title":"Comparison of Low-intensity Extracorporeal Shockwave Therapy and Low-intensity Laser Effects in Adhesive Capsulitis","status":"COMPLETED","sponsor":"Ahi Evran University Education and Research Hospital","startDate":"2023-01-21","conditions":"Adhesive Capsulitis","enrollment":65},{"nctId":"NCT05627921","phase":"NA","title":"The Effect of Botulinum Toxin and ESWT Applications on Spasticity and Functionality in Cerebral Palsy Patients","status":"UNKNOWN","sponsor":"Marmara University","startDate":"2022-11-15","conditions":"Cerebral Palsy, Spastic","enrollment":40},{"nctId":"NCT04440748","phase":"NA","title":"Feasibility Study and Pilot RCT Into the Use of a Novel Technology to Train Sitting Balance and Trunk Control","status":"COMPLETED","sponsor":"Jan Kool","startDate":"2021-04-08","conditions":"Stroke","enrollment":32},{"nctId":"NCT04917393","phase":"NA","title":"Multi-Organ Denervation With the iRF System to RedUce Sympathetic Drive","status":"UNKNOWN","sponsor":"Metavention","startDate":"2021-09-13","conditions":"Hypertension, Type 2 Diabetes, Metabolic Syndrome","enrollment":45},{"nctId":"NCT05131867","phase":"PHASE2","title":"Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2021-11-24","conditions":"Oral Nimodipine, Milrinone, Vascular Spasm After Traumatic Subarachnoidhaemorrhage","enrollment":30},{"nctId":"NCT05246800","phase":"NA","title":"The Effectiveness of a Mindfulness Application on Perceived Stess","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2018-03-01","conditions":"mHealth, Mindfulness, Stress","enrollment":587},{"nctId":"NCT03792945","phase":"PHASE4","title":"Comparison of the Efficacy of Corticosteroid Injection and ESWT in Patients With CTS","status":"COMPLETED","sponsor":"Ahi Evran University Education and Research Hospital","startDate":"2019-01-20","conditions":"Carpal Tunnel Syndrome, Tenosynovitis","enrollment":72},{"nctId":"NCT04224376","phase":"NA","title":"Improving Maximal Strength in the Initial Postoperative Phase After Anterior Cruciate Ligament Reconstruction Surgery: Randomized Controlled Trial of an App-Based Serious Gaming Approac","status":"COMPLETED","sponsor":"Hannover Medical School","startDate":"2016-04-01","conditions":"Anterior Cruciate Ligament Rupture","enrollment":26},{"nctId":"NCT02537080","phase":"NA","title":"The Effect of Nimodipine on the Postoperative Cognitive Dysfunction","status":"TERMINATED","sponsor":"University Hospital Hradec Kralove","startDate":"2015-09","conditions":"Mild Cognitive Impairment","enrollment":15},{"nctId":"NCT03150524","phase":"PHASE4","title":"RCVS: The Rational Approach to Diagnosis and Treatment","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2017-07-01","conditions":"Reversible Cerebral Vasoconstriction Syndrome","enrollment":""},{"nctId":"NCT02893826","phase":"PHASE1","title":"Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH","status":"TERMINATED","sponsor":"Edge Therapeutics Inc","startDate":"2016-09","conditions":"Subarachnoid Hemorrhage, Aneurysmal","enrollment":6},{"nctId":"NCT02790632","phase":"PHASE3","title":"Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage","status":"TERMINATED","sponsor":"Edge Therapeutics Inc","startDate":"2016-07","conditions":"Subarachnoid Hemorrhage, Aneurysmal","enrollment":374},{"nctId":"NCT02248233","phase":"PHASE4","title":"Nimodipine for Treating Acute Massive Cerebral Infarction","status":"COMPLETED","sponsor":"Fengtian Hospital","startDate":"2014-10","conditions":"Cerebral Infarction","enrollment":72},{"nctId":"NCT02774031","phase":"NA","title":"Comparison of Gas Consumption From Two Different Anesthesia Machines","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2016-05","conditions":"Male Urogenital Diseases, Female Urogenital Diseases","enrollment":147},{"nctId":"NCT01138683","phase":"PHASE3","title":"Cardiorenal Interactions During Treatment of Acute Decompensated Heart Failure: Diuretics Versus Ultrafiltration","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2010-02","conditions":"Acute Decompensated Heart Failure","enrollment":1},{"nctId":"NCT01220622","phase":"PHASE4","title":"Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes","status":"UNKNOWN","sponsor":"Ministry of Science and Technology of the People´s Republic of China","startDate":"2010-10","conditions":"Stroke, Mild Cognitive Impairment","enrollment":656}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":168,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["nimodipine","Nimotop"],"phase":"phase_3","status":"active","brandName":"Nimodipine group","genericName":"Nimodipine group","companyName":"University Hospital Hradec Kralove","companyId":"university-hospital-hradec-kralove","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nimodipine is a small molecule that acts as a mineralocorticoid receptor antagonist. It has been studied in various clinical trials for conditions such as subarachnoid hemorrhage, knee osteoarthritis, and stroke.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2007-04-17T00:00:00.000Z","mah":"SUN PHARM INDS INC","brand_name_local":"NIMODIPINE","application_number":"ANDA077067"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2007-05-02T00:00:00.000Z","mah":"HERITAGE","brand_name_local":"NIMODIPINE","application_number":"ANDA077811"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2008-01-17T00:00:00.000Z","mah":"BIONPHARMA","brand_name_local":"NIMODIPINE","application_number":"ANDA076740"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2013-05-10T00:00:00.000Z","mah":"AZURITY","brand_name_local":"NYMALIZE","application_number":"NDA203340"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2014-04-07T00:00:00.000Z","mah":"THEPHARMANETWORK LLC","brand_name_local":"NIMODIPINE","application_number":"ANDA090103"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2015-07-24T00:00:00.000Z","mah":"SOFGEN PHARMS","brand_name_local":"NIMODIPINE","application_number":"ANDA201832"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2024-07-09T00:00:00.000Z","mah":"ANNORA PHARMA","brand_name_local":"NIMODIPINE","application_number":"ANDA216937"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2025-01-22T00:00:00.000Z","mah":"ALKEM LABS LTD","brand_name_local":"NIMODIPINE","application_number":"ANDA213409"}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}